JAMA Ophthalmology (formerly Archives of Ophthalmology) is a monthly professional medical journal published by the American Medical Association. Archives of Ophthalmology publishes peer-reviewed ...

That’s the takeaway from a new study published in JAMA Ophthalmology. But doctors—including one of the study’s ...

According to a study published in the journal JAMA Ophthalmology, researchers went through medical records from 2008 to 2023 ...

they wrote in JAMA Ophthalmology. Over 3 years, the cumulative incidence of NAION were 8.9% and 6.7% in the two semaglutide groups, respectively, versus 1.8% and 0.8% for the non-GLP-1 groups.

In a news release published Monday on the results of the latest JAMA Ophthalmology study, the AAO noted that previous studies have linked semaglutide to blurred vision, worsening of diabetic ...

But the Mayo Clinic ophthalmologist who presented the findings stressed that it was “hugely reassuring” the GLP-1s were ...

A recent report 1 showed that 2 predisposing factors may have resulted in the development of spaceflight-associated ...

Patients taking semaglutide may be at an increased risk for an eye condition that can cause vision loss, according to a study published in JAMA Ophthalmology. The authors emphasized that more research ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Insurance claims data showed that patients with autoimmune ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

More information: Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide, JAMA Ophthalmology (2024). DOI: 10.1001/jamaophthalmol.2024.2296 Journal information ...